Compagos
Zurich, CH · 1 known investors
CompagOs develops Bon3OID, a biohardware platform that combines 3D bioprinted bone-like tissue constructs with hardware for controlled mechanical loading to produce functional readouts of bone remodeling. It serves preclinical drug development and translational diagnostics as a human-relevant in-vitro alternative to animal models for bone-focused research.
BiotechHardwareMedical Devices
Investors · 1
Frequently asked questions
- What does Compagos do?
- CompagOs develops Bon3OID, a biohardware platform that combines 3D bioprinted bone-like tissue constructs with hardware for controlled mechanical loading to produce functional readouts of bone remodeling. It serves preclinical drug development and translational diagnostics as a human-relevant in-vitro alternative to animal models for bone-focused research.
- Who are Compagos's investors?
- Compagos's investors include Kickfund.
- Where is Compagos headquartered?
- Compagos is headquartered in Zurich, CH.